ZA201005469B - Benzodiazepine compound and pharmaceutical composition - Google Patents

Benzodiazepine compound and pharmaceutical composition

Info

Publication number
ZA201005469B
ZA201005469B ZA2010/05469A ZA201005469A ZA201005469B ZA 201005469 B ZA201005469 B ZA 201005469B ZA 2010/05469 A ZA2010/05469 A ZA 2010/05469A ZA 201005469 A ZA201005469 A ZA 201005469A ZA 201005469 B ZA201005469 B ZA 201005469B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
benzodiazepine compound
benzodiazepine
compound
pharmaceutical
Prior art date
Application number
ZA2010/05469A
Other languages
English (en)
Inventor
Kunio Oshima
Takashi Oshiyama
Shinichi Taira
Yasuhiro Menjo
Hokuto Yamabe
Shuuji Matsumura
Masataka Ueda
Yasuo Koga
Kuninori Tai
Sunao Nakayama
Toshiyuki Onogawa
Kenji Tsujimae
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of ZA201005469B publication Critical patent/ZA201005469B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA2010/05469A 2008-02-22 2010-07-30 Benzodiazepine compound and pharmaceutical composition ZA201005469B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008041296 2008-02-22
JP2008227368 2008-09-04
PCT/JP2009/053623 WO2009104819A1 (en) 2008-02-22 2009-02-20 Benzodiazepine compound and pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA201005469B true ZA201005469B (en) 2011-11-30

Family

ID=40600203

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/05469A ZA201005469B (en) 2008-02-22 2010-07-30 Benzodiazepine compound and pharmaceutical composition

Country Status (26)

Country Link
US (2) US8338406B2 (enExample)
EP (1) EP2254873B1 (enExample)
JP (1) JP5355582B2 (enExample)
KR (1) KR101332948B1 (enExample)
CN (2) CN103554088B (enExample)
AR (1) AR070449A1 (enExample)
AU (1) AU2009216079B2 (enExample)
BR (1) BRPI0908132A2 (enExample)
CA (1) CA2715872A1 (enExample)
CO (1) CO6300950A2 (enExample)
CY (1) CY1115220T1 (enExample)
DK (1) DK2254873T3 (enExample)
ES (1) ES2494366T3 (enExample)
HR (1) HRP20140796T1 (enExample)
IL (1) IL207276A (enExample)
MX (1) MX2010009269A (enExample)
MY (1) MY156226A (enExample)
NZ (1) NZ587157A (enExample)
PL (1) PL2254873T3 (enExample)
PT (1) PT2254873E (enExample)
RU (1) RU2496775C2 (enExample)
SI (1) SI2254873T1 (enExample)
TW (1) TWI413522B (enExample)
UA (1) UA103018C2 (enExample)
WO (1) WO2009104819A1 (enExample)
ZA (1) ZA201005469B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2254873T3 (pl) 2008-02-22 2014-10-31 Otsuka Pharma Co Ltd Związek benzodiazepinowy i kompozycja farmaceutyczna
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
WO2011021676A1 (ja) 2009-08-21 2011-02-24 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン-2,4-ジオン化合物の製造方法
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物
WO2012149540A1 (en) 2011-04-28 2012-11-01 The Broad Institute Inc Inhibitors of histone deacetylase
AR090037A1 (es) 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
JP2014533258A (ja) 2011-11-15 2014-12-11 ゼンション・リミテッドXention Limited カリウムチャネル阻害剤としてのチエノ[2,3−c]ピラゾールの使用
EP2877444B1 (en) 2012-07-27 2020-09-02 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
JOP20190086A1 (ar) * 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
EA038455B1 (ru) * 2016-10-26 2021-08-31 Новартис Аг Новые производные нафтиридинона и их применение в лечении аритмии
RU2764243C2 (ru) 2017-09-22 2022-01-14 ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи Гетероциклические соединения в качестве ингибиторов PAD
CN111225915B (zh) 2017-10-18 2023-03-07 朱比兰特埃皮帕德有限公司 作为pad抑制剂的咪唑并吡啶化合物
US11629135B2 (en) 2017-11-06 2023-04-18 Jubilant Prodell Llc Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
RS65576B1 (sr) 2017-11-24 2024-06-28 Jubilant Episcribe Llc Heterociklična jedinjenja kao inhibitori prmt5
CA3125731A1 (en) 2018-01-12 2019-07-18 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
CN112105610B (zh) 2018-03-13 2024-01-26 朱比连特普罗德尔有限责任公司 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
BE707667A (enExample) 1966-12-14 1968-06-07
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
JPH0296133A (ja) * 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
BR9200951A (pt) 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
AU6895000A (en) 1999-08-09 2001-03-05 Merck & Co., Inc. Antiarrhythmic compounds
CN1596114A (zh) * 2001-11-13 2005-03-16 三维药物公司 取代的1,4-苯并二氮杂䓬类及其在治疗癌症中的应用
ES2401079T3 (es) 2002-12-20 2013-04-16 Amgen Inc. Moduladores del asma y de la inflamación alérgica
TWI329641B (en) 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
PL2254873T3 (pl) 2008-02-22 2014-10-31 Otsuka Pharma Co Ltd Związek benzodiazepinowy i kompozycja farmaceutyczna

Also Published As

Publication number Publication date
EP2254873A1 (en) 2010-12-01
CA2715872A1 (en) 2009-08-27
TW200940067A (en) 2009-10-01
PT2254873E (pt) 2014-08-29
US8338406B2 (en) 2012-12-25
TWI413522B (zh) 2013-11-01
KR101332948B1 (ko) 2014-01-17
CN103554088B (zh) 2016-02-24
US20130040941A1 (en) 2013-02-14
CO6300950A2 (es) 2011-07-21
JP5355582B2 (ja) 2013-11-27
PL2254873T3 (pl) 2014-10-31
SI2254873T1 (sl) 2014-07-31
KR20100124781A (ko) 2010-11-29
UA103018C2 (uk) 2013-09-10
US20100331317A1 (en) 2010-12-30
CN101952259A (zh) 2011-01-19
IL207276A (en) 2014-11-30
CN101952259B (zh) 2013-07-03
JP2011512324A (ja) 2011-04-21
ES2494366T3 (es) 2014-09-15
US8664217B2 (en) 2014-03-04
DK2254873T3 (da) 2014-06-30
MX2010009269A (es) 2010-09-14
HK1145461A1 (en) 2011-04-21
CN103554088A (zh) 2014-02-05
RU2496775C2 (ru) 2013-10-27
MY156226A (en) 2016-01-29
CY1115220T1 (el) 2017-01-04
WO2009104819A1 (en) 2009-08-27
RU2010138928A (ru) 2012-03-27
NZ587157A (en) 2012-05-25
AR070449A1 (es) 2010-04-07
EP2254873B1 (en) 2014-06-04
AU2009216079B2 (en) 2013-08-22
IL207276A0 (en) 2010-12-30
BRPI0908132A2 (pt) 2015-08-04
HRP20140796T1 (hr) 2014-10-24
AU2009216079A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
IL207276A0 (en) Benzodiazepine compound and pharmaceutical composition
IL228817A0 (en) Pharmaceutical compounds
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
HRP20220585T3 (hr) Oligopeptidni spojevi i njihove uporabe
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
EP2224915A4 (en) PHARMACEUTICAL COMPOSITIONS
IL211886A0 (en) Solid pharmaceutical composition
IL232457A0 (en) Quinolone compound and pharmaceutical preparation
IL208387A0 (en) Pharmaceutical composition
IL201894A0 (en) Quinolone compound and pharmaceutical composition
EP2224808A4 (en) PHARMACEUTICAL COMPOSITION
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
ZA201100871B (en) Solid pharmaceutical composition
ZA201006224B (en) Pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
PL2236145T3 (pl) Kompozycja farmaceutyczna i lek złożony
GB0817969D0 (en) Pharmaceutical composition
EP2114404A4 (en) COMPOUND AND PHARMACEUTICAL COMPOSITION
AP2734A (en) Pharmaceutical carrier composition and pharmaceutical composition
AP2007004032A0 (en) Pharmaceutical carrier composition and pharmaceutical composition
PL2231117T3 (pl) Kompozycja farmaceutyczna zawierająca benzodiazepinę i/lub pochodne benzodiazepiny
GB0817974D0 (en) Pharmaceutical composition
GB0817566D0 (en) Pharmaceutical composition